Brief Intervention for Drug Abuse Using the WHO ASSIST

使用 WHO ASSIST 对药物滥用进行简短干预

• 批准号: 7106402
• 负责人: THOMAS F BABOR
• 金额: $ 40.51万
• 依托单位: UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-08-01 至 2009-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7106402
• 关键词: Cannabis; behavior therapy; behavioral /social science research tag; clinical research; cocaine; diagnosis design /evaluation; drug abuse; drug abuse therapy; human subject; human therapy evaluation; international cooperation; methamphetamine; motivation; opiate alkaloid; outcomes research; patient oriented research; self help

DESCRIPTION (provided by applicant): This proposal describes a 3-year study that will investigate the effectiveness of a Brief Intervention (BI) for high risk (non-dependent) use of illicit drugs as linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), a new instrument developed by the World Health Organization (WHO). The ASSIST was recently developed by an international group of researchers to screen for problem or risky use of tobacco, alcohol, cannabis, cocaine, amphetamines, sedatives, hallucinogens, inhalants, opiates and other drugs. The proposed study will allow US participation in an international multi-site collaborative project to evaluate the effectiveness of a brief intervention for four illicit drugs (cannabis, amphetamines, cocaine and opiates) as linked to the WHO ASSIST. The study will use a randomized controlled design in which eligible patients (N=160 non-dependent users of four illicit substances) presenting for care at a large dental clinic will be randomly assigned to either an experimental condition or a waitlist control group. Experimental subjects will receive a brief motivational intervention for the drug with the highest ASSIST severity score as well as self-help materials relating to that drug. Both groups will be re-assessed at three and six months with the ASSIST and related outcome measures. The project will be conducted independently at the University of Connecticut but will be linked to a larger multi-site study being sponsored by WHO at collaborating international sites where an additional 740 participants will be recruited.

描述（由申请人提供）： 该提案描述了一项为期 3 年的研究，该研究将调查与酒精、吸烟和物质参与筛查测试 (ASSIST)（世界卫生组织 (WHO) 开发的一种新工具）相关的高风险（非依赖性）非法药物使用的简短干预 (BI) 的有效性。 ASSIST 最近由一个国际研究小组开发，用于筛查烟草、酒精、大麻、可卡因、安非他明、镇静剂、致幻剂、吸入剂、阿片剂和其他药物的问题或危险使用。拟议的研究将使美国能够参与一项国际多地点合作项目，以评估与世界卫生组织 ASSIST 相关的四种非法药物（大麻、安非他明、可卡因和阿片制剂）的简短干预措施的有效性。该研究将采用随机对照设计，其中在大型牙科诊所就诊的符合条件的患者（N = 160 名四种非法物质的非依赖性使用者）将被随机分配到实验组或候补对照组。实验对象将接受针对 ASSIST 严重程度评分最高的药物的简短激励干预，以及与该药物相关的自助材料。两组将在三个月和六个月时使用 ASSIST 和相关结果指标进行重新评估。该项目将在康涅狄格大学独立进行，但将与世卫组织在国际合作地点赞助的一项更大规模的多地点研究相关联，该研究将另外招募 740 名参与者。